Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Breast Cancer Clinical Trial
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Locally Advanced or Metastatic Solid Tumors Clinical Trial
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Locally Advanced or Metastatic Solid Tumors Clinical Trial
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Locally Advanced or Metastatic Solid Tumors Clinical Trial
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Austin, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gynecologic Cancer Clinical Trial
PSMA PET and MRI in Gynecological Cancers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of SY-1365 in Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Study With CY, Pembrolizumab, GVAX, and SBRT in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biliary Cancer Clinical Trial
Pembrolizumab and GM-CSF in Biliary Cancer
Status: Enrolling, Phase II
Updated: 4/25/2018
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Little Rock, AR
Click here to add this to my saved trials
Oncology Clinical Trial
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
Status: Enrolling
Updated: 2/6/2018
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
BATTLE-2 Program - A Biomarker-Integrated Targeted Therapy in Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Extracellular RNA Markers of Liver Disease and Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Lebanon, NH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Decatur, IL
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Jackson, MS
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Helena, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of TSR-033 With an Anti-PD-1
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Madison, WI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
trūFreeze® Palliative Esophageal Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Farmington, NM
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
Status: Enrolling, Phase
Updated: 4/18/2018
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
Status: Enrolling, Phase
Updated: 4/18/2018
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Sym021 Monotherapy and in Combination With Sym022 or Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Aurora, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bend, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bloomington, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boise, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Boone, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Bozeman, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Centralia, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clackamas, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Concord, NH
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Dodge City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
East Lansing, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
East Stroudsburg, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Elmira, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Everett, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
1 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 530